BSE filing, NSE: SHREEGANES. Summary written from the filing by ALFA Finder's alert engine.
Shree Ganesh Bio-Tech (India) Ltd: key numbers
- Share price
- ₹0.43
- Market cap
- ₹17.14 Cr
- Revenue (annual)
- ₹4.97 Cr
- Net profit (annual)
- ₹0.38 Cr
- P/E (TTM)
- -44.4×Sector 45.9×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 1.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ganesh Bio-Tech (India) Ltd
All →Shree Ganesh Bio-Tech (India) Board Meeting Date
Shree Ganesh Biotech will hold a board meeting on November 2, 2026 for unaudited results. The agenda is proposed and the meeting has not yet occurred.
Shree Ganesh Bio-Tech (India) Other Announcement
Company submitted its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended September 2026.
Shree Ganesh Bio-Tech (India) Annual General Meeting
Shree Ganesh Biotech (India) Limited held its 16th Annual General Meeting on 28th September 2026, where shareholders adopted financial statements and re-appointed a director.
Shree Ganesh Bio-Tech (India) Annual Report
Shree Ganesh Bio-Tech (India) Limited has released its Annual Report for the financial year 2025-26. The 16th Annual General Meeting is scheduled for September 28, 2026.
Shree Ganesh Bio-Tech (India) Annual General Meeting
Shree Ganesh Bio-Tech (India) Limited has issued a notice for its 16th Annual General Meeting. The meeting is scheduled for September 28, 2026, at the registered office.
Shree Ganesh Bio-Tech (India) Other Announcement
Shree Ganesh Biotech (India) Limited has updated its official website address to www.shreeganeshbiotech.bar. Exchanges are requested to update their records accordingly.
Other other announcement announcements
All →Purple Style Labs Other Announcement
Purple Style Labs Limited (unlisted) filed its quarterly shareholding pattern for the quarter ended 30 September 2026 under Regulation 31(1)(b). It is a routine periodic disclosure with no transaction or money involved.
Chemkart India Other Announcement
Chemkart India reported no IPO fund deviation for the half year ended 30 September 2026. Rs.39.48 Crore of Rs.64.47 Crore allocation is utilised.
Zee Entertainment Enterprises Other Announcement
Zee Entertainment updated its authorised KMP list for Reg 30 disclosures, effective 2 November 2026, after a Company Secretary change. No money or business event is involved.
Pranav Constructions Other Announcement
Pranav Constructions filed Crisil's monitoring agency report on IPO proceeds for the quarter ended September 2026. It reports no deviation from the issue objects.
Tempsens Instruments (India) Other Announcement
Tempsens Instruments reported no deviation in IPO fund utilisation for the quarter ended 30 September 2026. This is a routine Regulation 32 statement.
GMR Power and Urban Infra Other Announcement
GMR Power filed a monitoring agency report for the quarter ended September 30, 2026. Preferential issue proceeds are fully utilised, with no deviation from the offer document.